Scarica l'app Stockscreener
5.472
3.61%
0.212
Precedente Chiudi:
$5.26
Aprire:
$5.3
Volume 24 ore:
245.50K
Relative Volume:
0.36
Capitalizzazione di mercato:
$372.90M
Reddito:
-
Utile/perdita netta:
$-96.66M
Rapporto P/E:
-2.5451
EPS:
-2.15
Flusso di cassa netto:
$-83.73M
1 W Prestazione:
+17.46%
1M Prestazione:
+18.74%
6M Prestazione:
+9.66%
1 anno Prestazione:
-56.01%
Intervallo 1D:
$5.29
$5.54
Intervallo di 1 settimana:
$4.47
$5.58
Portata 52W:
$2.86
$13.93
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
Nome
Olema Pharmaceuticals Inc
Settore
Industria
Telefono
(415) 651-3316
Indirizzo
780 BRANNAN STREET, SAN FRANCISCO
Confronta OLMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
5.45 | 361.70M | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.89 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
574.64 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.07 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
649.12 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.76 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-02 | Iniziato | Goldman | Buy |
| 2024-01-30 | Iniziato | Citigroup | Buy |
| 2023-07-21 | Iniziato | Oppenheimer | Outperform |
| 2023-05-05 | Iniziato | CapitalOne | Overweight |
| 2023-02-22 | Iniziato | Credit Suisse | Outperform |
| 2022-07-06 | Ripresa | Canaccord Genuity | Buy |
| 2022-06-09 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | Iniziato | H.C. Wainwright | Neutral |
| 2021-12-07 | Ripresa | Cowen | Outperform |
| 2020-12-14 | Iniziato | Canaccord Genuity | Buy |
| 2020-12-14 | Iniziato | Cowen | Outperform |
| 2020-12-14 | Iniziato | JP Morgan | Overweight |
| 2020-12-14 | Iniziato | Jefferies | Buy |
Mostra tutto
Olema Pharmaceuticals Inc Borsa (OLMA) Ultime notizie
What high frequency data says about Olema Pharmaceuticals Inc.July 2025 Momentum & Free Fast Entry Momentum Trade Alerts - Newser
Is Olema Pharmaceuticals Inc. a defensive stockGap Down & Step-by-Step Trade Execution Guides - mustnews.co.kr
Identifying reversal signals in Olema Pharmaceuticals Inc.Breakout Watch & Risk Controlled Swing Trade Alerts - Newser
What makes Olema Pharmaceuticals Inc. stock price move sharply2025 Market Overview & Weekly High Return Opportunities - Newser
Is it too late to sell Olema Pharmaceuticals Inc.Rate Hike & Growth Oriented Trading Recommendations - Newser
Combining price and volume data for Olema Pharmaceuticals Inc.Quarterly Profit Report & Weekly Market Pulse Updates - Newser
Olema Pharmaceuticals (NASDAQ:OLMA) Posts Earnings Results, Misses Expectations By $0.08 EPS - MarketBeat
Applying big data sentiment scoring on Olema Pharmaceuticals Inc.Portfolio Return Report & Weekly Breakout Stock Alerts - Newser
How hedge fund analytics apply to Olema Pharmaceuticals Inc. stockPortfolio Risk Report & Comprehensive Market Scan Insights - Newser
Is Olema Pharmaceuticals Inc. in Accumulation Phase NowQuarterly Portfolio Report & Daily Chart Pattern Signals - sundaytimes.kr
Applying Elliott Wave Theory to Olema Pharmaceuticals Inc.July 2025 Intraday Action & AI Enhanced Market Trend Forecasts - Newser
What institutional flow reveals about Olema Pharmaceuticals Inc.Analyst Upgrade & Community Verified Watchlist Alerts - Newser
Olema Pharmaceuticals (NASDAQ:OLMA) Price Target Raised to $21.00 - MarketBeat
What’s next for Olema Pharmaceuticals Inc. stock price2025 Market Outlook & Growth Focused Investment Plans - Newser
Published on: 2025-08-13 05:28:51 - Newser
Volatility clustering patterns for Olema Pharmaceuticals Inc.Weekly Gains Report & Growth Focused Entry Point Reports - Newser
Olema Pharmaceuticals (NASDAQ:OLMA) Price Target Raised to $21.00 at Citigroup - Defense World
Key metrics from Olema Pharmaceuticals Inc.’s quarterly data2025 Macro Impact & Reliable Volume Spike Trade Alerts - Newser
Clinical Trial Progress and Analyst Endorsement Spark Short-Term Rebound for Olema Pharmaceuticals - Insider Monkey
A Quick Look at Today's Ratings for Olema Pharmaceuticals(OLMA.US), With a Forecast Between $21 to $28 - 富途牛牛
Olema Pharmaceuticals Stays On Track Despite Wider Losses - Finimize
Does Olema Pharmaceuticals Inc. qualify in momentum factor screeningIntraday Price Forecast Using Volume Models - Newser
Olema Pharmaceuticals Advances Breast Cancer Therapies - TipRanks
Olema Pharma Q2 net loss widens to $43.8 mln - MarketScreener
Olema Oncology Reports Second Quarter 2025 Financial and Operating Results - GlobeNewswire
Can Olema Pharmaceuticals Inc. Outperform Peers After Recent PullbackHigh Probability Trade Forecast Summary - beatles.ru
Momentum divergence signals in Olema Pharmaceuticals Inc. chartCapital Growth Summary Over Five Years - Newser
What to expect from Olema Pharmaceuticals Inc. in the next 30 daysSmart Entry Watchlist with Daily Analysis - Newser
Is a relief rally coming for Olema Pharmaceuticals Inc. holdersTrend Reversal Probability Forecast Update - Newser
11 Best Short-Term Stocks to Invest in - Insider Monkey
Trendlines Converge — Decision Point for Olema Pharmaceuticals Inc.Consistent Income Focused Trade List Analyzed - beatles.ru
How to use a screener to detect Olema Pharmaceuticals Inc. breakoutsDaily Stock Watch Summary with Key Insights - Newser
Why Olema Pharmaceuticals Inc. stock attracts strong analyst attentionFundamental Forecast for Undervalued Stocks - Newser
Can a trend reversal in Olema Pharmaceuticals Inc. lead to recoveryRisk Managed Watchlist with Breakout Picks - Newser
Olema Pharmaceuticals Inc expected to post a loss of 38 cents a shareEarnings Preview - TradingView
Olema Pharmaceuticals Inc Azioni (OLMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.44%
0.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):